# Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification

> **NCT05440721** · NA · WITHDRAWN · sponsor: **Click Therapeutics, Inc.**

## Conditions studied

- Nicotine Addiction
- Drug Addiction
- Drug Dependence
- Substance Use Disorder
- Tobacco Dependence

## Interventions

- **DEVICE:** Treatment A with device Clickotine® (Active intervention)
- **DEVICE:** Treatment B with smoking education (control)

## Key facts

- **NCT ID:** NCT05440721
- **Lead sponsor:** Click Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-10-25
- **Primary completion:** 2022-07
- **Final completion:** 2022-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Change of company's priority; learning from a separate CT-101-CLS-001 (NCT04857515) is deemed sufficient
- **Last updated:** 2022-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05440721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05440721, "Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05440721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*